Disclosures for "Opakalim (BHV-7000) Potentiates the Activity of Kv7.2/7.3 Channels Containing a Single Copy of the Kv7.2 DEE-Causing Mutation, G281E"
-
Dr. Spitznagel has nothing to disclose.
-
Dr. Komarov has nothing to disclose.
-
Ms. DeMarco has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. DeMarco has stock in Biohaven Pharmaceuticals.
-
Ms. Smith has nothing to disclose.
-
Dr. Wang has nothing to disclose.
-
Lynn Resnick has received personal compensation for serving as an employee of Biohaven. Lynn Resnick has stock in Biohaven. Lynn Resnick has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Picchione has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Picchione has stock in Biohaven Pharmaceuticals.
-
Dr. Lerner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Lerner has stock in Biohaven Pharmaceuticals.
-
Dr. Weaver has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Weaver has stock in Biohaven Pharmaceuticals. Dr. Weaver has stock in WaveFront Biosciences, L.L.C.. An immediate family member of Dr. Weaver has stock in ION Biosciences.
-
Dr. Dworetzky has received personal compensation for serving as an employee of Biohaven. Dr. Dworetzky has stock in Biohaven. Dr. Dworetzky has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Bozik has received personal compensation for serving as an employee of Biohaven . Dr. Bozik has stock in Biohaven.